Salvage treatment for children with relapsed/refractory germ cell tumors: The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) experience.
Maria Debora De PasqualePaolo D'AngeloAlessandro CrocoliRenata BoldriniMassimo ConteGianni BisognoFilippo SpreaficoAlessandro InserraDavide BiasoniPatrizia Dall'IgnaFortunato SiracusaEvelina MieleMonica TerenzianiPublished in: Pediatric blood & cancer (2019)
SLCT followed or not by HDCT is an effective salvage treatment for children with relapsed/refractory GCTs. However, the role of HDCT following SLCT needs to be further investigated, especially regarding the identification of specific patient subgroups, which can benefit from this more intensive treatment.